HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Horikoshi Selected Research
M Horikoshi Research Topics
Disease
4
Type 2 Diabetes Mellitus (MODY)
08/2009 - 07/2005
2
Lung Neoplasms (Lung Cancer)
11/2000 - 01/2000
1
Muscular Diseases (Myopathy)
11/2017
1
Pathologic Constriction (Stenosis)
11/2017
1
Glucose Intolerance
12/2012
1
Arthritis (Polyarthritis)
05/2011
1
Experimental Arthritis
05/2011
1
Multiple Hereditary Exostoses (Hereditary Multiple Exostoses)
12/2007
1
Obesity
12/2007
1
Melanoma (Melanoma, Malignant)
03/2001
1
Bronchogenic Carcinoma
11/2000
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2000
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2000
1
Stomach Neoplasms (Stomach Cancer)
01/2000
1
Essential Thrombocythemia
01/2000
Drug/Important Bio-Agent (IBA)
1
Signal Recognition Particle
IBA
11/2017
1
Glucose (Dextrose)
FDA Link
Generic
12/2012
1
Ligands
IBA
05/2011
1
Glycolipids
IBA
05/2011
1
dicarboxydine (DCD)
IBA
08/2009
1
zinc-binding protein (zinc binding protein)
IBA
12/2007
1
Insulin-Like Peptides
IBA
12/2007
1
Carrier Proteins (Binding Protein)
IBA
12/2007
1
Proteins (Proteins, Gene)
FDA Link
12/2007
1
Messenger RNA (mRNA)
IBA
12/2007
1
Cyclin-Dependent Kinase Inhibitor p15
IBA
12/2007
1
Transcription Factors (Transcription Factor)
IBA
04/2007
1
Adiponectin Receptors
IBA
07/2005
1
Gadolinium
IBA
03/2001
1
Antibodies
IBA
03/2001
1
S100 Proteins (S 100 Protein)
IBA
03/2001
1
Technegas
IBA
11/2000
1
Hydroxyurea (Hydrea)
FDA Link
Generic
01/2000
1
Tegafur
IBA
01/2000
1
Radioisotopes (Radionuclides)
IBA
01/2000
1
Uracil
IBA
01/2000
Therapy/Procedure
2
Aftercare (After-Treatment)
11/2000 - 01/2000
1
Drug Therapy (Chemotherapy)
01/2000
1
Radiotherapy
01/2000
1
Therapeutics
01/2000